Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5264_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Editors’ Bio
- •1.1 Introduction
- •1.2 Nervous System Development
- •1.2.1 Spinal Cord Development
- •1.3 Touch and Pain
- •1.5 Artificial Brain and Neural Networks
- •1.5.1 Neural Networks
- •1.5.1.1 Biological Neural Networks
- •1.5.2 Artificial Intelligence (AI)
- •1.6 Neurodegenerative Diseases
- •1.7 Drugs for Brain Disorders
- •1.8 Conclusion
- •References
- •2.1 Introduction
- •1.4 Memory and Learning
- •1.4.1 Types of Memory
- •2.2 Herbs Exhibiting Neuroprotective Properties
- •2.2.1 Ginkgo Biloba L.
- •2.2.2 Panax Ginseng
- •2.2.3 Bacopa Monnieri
- •2.2.4 Terminalia Chebula
- •2.2.5 Convolvulus Pluricaulis
- •2.3.1 Polyphenols
- •2.3.1.1 Flavonoids
- •2.3.1.2 Phenolic Acid
- •2.3.1.3 Tannins
- •2.3.2 Vitamins
- •2.3.3 Alkaloids
- •2.4 Conclusion
- •References
- •3.1 Introduction
- •3.2 Etymology of MANA
- •3.2.1 Manovaha Srotas Kritya
- •3.2.3 Centres Located in Manas
- •3.3 Structural Qualities of Manas
- •3.4 Sensual Perception
- •3.4.2 Qualities of Mana
- •3.4.3 English Equivalent of Component & Functions
- •3.4.4 Characters of an Individual Derived in the Fetus From Manas
- •3.7.3 Ahiphena (Papaver Somniferum)
- •3.7.8 Tagara (Valeriana Wallichii)
- •3.7.11 Common Useful Herbs-Mineral Yogas of Psychotropic Drugs
- •3.8 Conclusion
- •References
- •4.1 Introduction
- •4.5.1 Cell Line Studies
- •4.5.2 Animal Model Studies
- •4.5.3 Human Clinical Trials
- •4.7 Further Considerations
- •4.7.1 Food-Drug and Drug-Drug Interactions
- •4.8 Concluding Remarks
- •References
- •5.1 Introduction
- •5.2 Herbal Medicines in Health and Disease
- •5.4 Plants and Herbs With Nootropic Abilities
- •5.5 Plant Bioactive Compounds With Nootropic Activities
- •5.5 Conclusion
- •Terms and Abbreviations
- •References
- •6.1 Introduction
- •6.2 Therapeutic Potential of Indian Traditional Plants
- •6.2.1 Bacopa Monnnieri (L.) Pennell (Family: Plantaginaceae)
- •6.2.1.1 Neuroprotection in Alzheimer’s Disease
- •6.2.1.2 Neuroprotection in Parkinson’s Disease
- •6.2.2 Centella Asiatica (L.) Urban (Family: Apiaceae)
- •6.2.2.1 Neuroprotection in Alzheimer’s Disease
- •6.2.2.2 Neuroprotection in Parkinson’s Disease
- •6.2.3 Curcuma Longa L. (Family: Zingiberaceae)
- •6.2.3.1 Neuroprotection in Alzheimer’s Disease
- •6.2.3.2 Neuroprotection in Parkinson’s Disease
- •6.2.4 Withania Somnifera (L.) Dunal. (Family: Solanaceae)
- •6.2.4.1 Neuroprotection in Alzheimer’s Disease
- •6.2.4.2 Neuroprotection in Parkinson’s Disease
- •6.2.5 Nardostachys Jatamansi (D. Don) DC. (Family: Caprifoliaceae)
- •6.2.5.1 Neuroprotection in Alzheimer’s Disease
- •6.2.5.2 Neuroprotection in Parkinson’s Disease
- •6.3 Conclusion
- •References
- •7.1 Introduction
- •7.2 Hippocampus
- •7.3 Acetylcholine
- •7.4 Dementia
- •7.5 Nootropics
- •7.5.1 Natural Nootropics
- •7.5.2 Allium Sativum (Family: Amaryllidaceae)
- •7.5.3 Asparagus Racemosus (Family: Asparagaceae)
- •7.5.4 Benincasa Hispida (Family: Cucurbitaceae)
- •7.5.5 Clitoria Ternatea (Family: Fabaceae)
- •7.5.6 Cyperus Rotundus (Family: Cyperaceae)
- •7.5.7 Embelia Ribes (Family: Primulaceae)
- •7.5.8 Huperzia Serrata (Family: Lycopodiaceae)
- •7.5.9 Marsilea Minuta (Family: Marsileaceae)
- •7.5.10 Piper Betel (Family: Piperaceae)
- •7.5.11 Polygala Tenuifolia (Family: Polygalaceae)
- •7.5.13 Vitis Vinifera (Family: Vitaceae)
- •7.6 Conclusion
- •References
- •8.1 Introduction
- •8.2 Amyloidoses
- •8.3 Prion Diseases
- •8.4 Tauopathies
- •8.5 Alzheimer’s Disease
- •8.6 Chronic Traumatic Encephalopathy (CTE)
- •8.7 Progressive Supranuclear Palsy (PSP)
- •8.8 Cortico-Basal Degeneration (CBD)
- •8.9 Synucleinopathies
- •8.10 TDP-43 (Proteinopathies)
- •8.11 Approved Therapies
- •8.12 Marine Natural Products
- •8.13 Conclusion
- •References
- •9.1 Introduction
- •9.2 Phytoconstituents of Walnut
- •9.2.1 Amino Acids
- •9.2.2 Dietary Fibre and Phytosterols
- •9.2.3 Minerals and Vitamins
- •9.2.4 Vitamin E
- •9.2.5 Vitamin B6
- •9.2.6 Vitamin B9
- •9.2.7 Minerals
- •9.3 Therapeutic Benefits of Brain Food
- •9.3.1 Cognitive Benefit
- •9.3.2 Ageing and Metabolic Effects On Brain Health
- •9.5.1 Animal Studies
- •9.5.2 Clinical Trials in Humans
- •9.6 Conclusion
- •References
- •10.1 Introduction
- •10.2 Brief Attention On NDDs
- •10.2.1 Alzheimer’s Disease (AD)
- •10.2.2 Parkinson’s Disease (PD)
- •10.2.2.2 Neuropsychiatric Disorders
- •10.3 Conclusion and Outlook
- •References
- •11.1 Introduction
- •11.2 Polyphenolsstructure and Classification
- •11.3 Neurodegenerative Disorders
- •11.4 Role of Plant Phenol On Neurochemistry
- •11.5.1 Alzheimer’s Disease
- •11.5.2 Parkinson’s Disease
- •11.5.3 Huntington’s Disease
- •11.6 Conclusion
- •References
- •12.1 Introduction
- •12.2 Phytochemicals and Their Classification
- •12.2.1 Alkaloids
- •12.2.2 Phenolics
- •12.2.3 Terpenoids
- •12.2.4 Saponins
- •12.2.5 Phytosterols
- •12.2.6 Cardiac Glycoside
- •12.3 Phytochemical Extraction Techniques
- •12.3.1 Conventional Methods for Extraction
- •12.3.2 Modern Methods for Extraction
- •12.3.2.1 Supercritical Fluid Extraction
- •12.4.2 Phytochemicals as Nrf2 Activators in Autism Spectral Disorder (ASD)
- •12.5 Conclusion
- •Contribution of Authors
- •Conflict of Research Interests
- •References
- •13.1 Introduction
- •13.2 Traditional Preparations and Formulations
- •13.2.1 Chyawanprash
- •13.2.2 Abana
- •13.2.3 Bramhi Ghrita
- •13.2.4 Memorin
- •13.2.5 Brain-O-Brain
- •13.2.6 Shimotsu-To
- •13.5 The Inclination for Natural Products Over Synthetics
- •13.7 Conclusion
- •References
- •14.1 Introduction
- •14.2 List of Edible Alkaloids
- •143 Biosynthesis of Tryptophan
- •14.4 Biosynthesis of Galantamine
- •14.5 General Biosynthesis of Indole Alkaloids (Figure 14.3)
- •14.6 Toxicity of Edible Alkaloids
- •14.7 Effect of β-Carboline On Memory & Behaviour
- •14.8 Effect of Murraya Koenigii On Memory & Behaviour
- •14.9 Effect of Anonaine On Memory & Behaviour
- •14.10 Conclusion
- •References
- •15 Caffeine and Motor Skills
- •15.1 Introduction
- •15.1.1 Pharmacological Profile and Pharmacokinetics
- •15.1.2 Stimulant Properties
- •15.2 Motor Skills in Normal Subjects
- •15.2.1 Human Subjects
- •15.2.2 Mice and Rats
- •15.2.3 Human Development
- •15.2.4 Rodent Development
- •15.3 Drug Interactions
- •15.3.1 Ethanol
- •15.3.2 Other Sedatives and Benzodiazepines
- •15.3.3 Glutamate
- •15.3.4 Pesticides
- •15.4 Hypoxia/ischaemia and Hypoglycaemia
- •15.4.1 Hypoxia/ischaemia
- •15.4.2 Hypoglycaemia
- •15.5 Traumatic Injury
- •15.5.1 Brain Trauma
- •15.5.2 Spinal Trauma
- •15.6 Non-Cerebellar Neurodegenerative Diseases
- •15.6.1 Amyotrophic Lateral Sclerosis
- •15.6.2 Parkinson’s Disease
- •15.6.3 Alzheimer’s Disease
- •15.7 Cerebellar Disorders
- •15.7.1 Episodic Ataxia Types 1 and 2
- •15.7.2 Spinocerebellar Atrophy
- •15.7.3 Ataxia Telangiectasia
- •15.7.4 Joubert Syndrome
- •15.8 Huntington’s Disease
- •15.9 Concluding Remarks
- •Acknowlegments
- •References
- •16 Melatonin and the Brain
- •16.1 Introduction
- •16.2 Dietary Sources of Melatonin
- •16.2.1 Animal Foods
- •16.2.2 Plant Foods
- •16.2.3 Juices and Beverages
- •16.3 Bioavailability of Melatonin in Humans
- •16.4 Melatonin Synthesis and Metabolism
- •16.5 Pharmacokinetic Properties of Melatonin
- •16.6 Melatonin Receptors
- •16.6.1 MT1 Receptor
- •16.6.2 MT2 Receptor
- •16.6.3 MT3 Receptor
- •16.6.4 Retinoic Acid Receptor-Related Orphan Receptor (ROR)
- •16.7 Mechanism of Action of MT
- •16.8 Melatonin in the Central Nervous System
- •16.8.1 Neuroprotective Capacity
- •16.8.2 Anti-Ischaemic and Anti-Oxidative Effects of Melatonin
- •16.8.3 Anti-Oxidative Effects of Melatonin in Alzheimer’s Disease
- •16.9 Anti-Depressant-Like Action of Melatonin
- •16.10 Conclusion
- •References
- •17 Narcotics and Brain Health
- •17.1 Introduction
- •17.2 Biological Elements Make Addiction to Drugs More Likely
- •17.2.1 Environmental Risk Factors
- •17.2.2 Additional Elements Boost the Chances of Drug Addiction
- •17.3 Drugs Harm the Brain Cells Permanently
- •17.3.1 Opioid Overdose and Brain Injury
- •17.3.2 Alcoholic Effects On the Brain
- •17.3.3 Stimulant Effects On the Brain
- •17.4 Narcotics and Brain Health
- •17.5 How Do Narcotics Make You Feel Good?
- •17.5.1 Dopamine’s Role in Drug Use Reinforcement
- •17.8 Addiction: Is It Curable?
- •17.8.1 Is a Drug Relapse a Sign That Therapy Was Ineffective?
- •17.9 Devices and Medications for the Treatment of Drug Abuse
- •17.9.1 Treatment for Withdrawal
- •17.9.2 Remaining in Therapy
- •17.9.3 Avoiding Relapse
- •17.9.4 Treatment With Behavioural Therapy
- •17.11 Conclusion
- •References
- •18 Nutraceuticals in Brain Health
- •18.1 Introduction
- •18.4 Nutraceuticals in Alzheimer’s Disease
- •18.4.1 Apigenin and Luteolin
- •18.4.2 Flavonoids
- •18.4.3 Crocin
- •18.4.4 Carotenoids
- •18.4.5 Anthocyanidins
- •18.5 Nutraceuticals in Parkinson’s Disease
- •18.6 Nutraceuticals in Depression
- •18.7 Nutraceuticals in Multiple Sclerosis
- •18.8 Nutraceuticals in Hungtington’s Disease
- •18.9 Nutraceuticals in Psychotic Disorders
- •18.10.1 Nutraceuticals Enhance Biogenesis and Maintain Mitochondrial Health
- •18.11 Conclusion
- •References
- •19.1 Introduction
- •19.3 The Brainstem
- •19.4 The Development of the Medulla
- •19.5 The Development of the Midbrain
- •19.6 Role of Thyroid Hormone in Fetal Brain Development
- •19.8 Food
- •19.8.1 Dietary Guidelines During Pregnancy
- •19.9 Discussion
- •19.10 Conclusion
- •References

164
Plant-based Foods and their Implications in Brain Health
Fungus
Sl. No. Marine source Scientific name Source of collection Chemical compound isolated Nature of chemical Chemical structure Mechanism of action References
(22E,24R)- ergosta- 5,22- dien-
(22E,24R)- ergosta- 4,6,8(14),22-
tetraen- 3- one
9. Marine originated
fungus
Aspergillus sp.
SCS- KFD66
isolated from a bivalve mollusc
Sanguinolaria chinensis, which
was collected from Haikou Bay,
China
Asperpenes D Terpenoids
Asperpenes E
10. Marine originated
fungus
A. terreus
BCC51799
isolated from a decayed wood
sample from the Gulf of Thailand
Territrem B Terpenoids
11. Marine originated
fungus
A. terreus
SCSGAF0162
isolated from a gorgonian coral
Echinogorgia aurantiaca, which
was collected from the South
China Sea
Territrems C Terpenoids
TABLE 8.2 (Continued)
The structure of various chemical compounds isolated from marine sources of fungus

165165
Marine Plant Species: Nutritional and Medicinal Value
(continued)
Terpenoids
(Meroterpenoids)
weak inhibitory activity
against AChE
145
Terpenoids
(Meroterpenoids)
anti- AChE activity with
IC
50
= 0.071 µM (IC
50
of galantamine
146
Terpenoids
(Meroterpenoids)
anti- AChE activity 147

166
Plant-based Foods and their Implications in Brain Health
Fungus
Sl. No. Marine source Scientific name Source of collection Chemical compound isolated Nature of chemical Chemical structure Mechanism of action References
Territrems D
Territrems E
Arisugacin
Terreulactone C
12. endophytic fungus Penicillium sp.
SK5GW1L
isolated form leaves of a
mangrove tree
K. candel
Terpenoids
3- epiarigsugacin E
Arisugacin B
Arisugacin D
13. endophytic fungus A. avus (8E,12Z)- 10,11-
dihydroxyoctadeca- 8,12-
dienoic acid
TABLE 8.2 (Continued)
The structure of various chemical compounds isolated from marine sources of fungus

167
Marine Plant Species: Nutritional and Medicinal Value
(Meroterpenoids)
potent inhibitory activity 148
Marine Fatty Acids
weak AChE inhibitory
activity
149
(continued)

168
Plant-based Foods and their Implications in Brain Health
Fungus
Sl. No. Marine source Scientific name Source of collection Chemical compound isolated Nature of chemical Chemical structure Mechanism of action References
14. marine originated
fungus
Biscogniauxia
mediterranea
strain LF657
isolated from a sediment collected in
Eastern Mediterranean Sea
cyclo- (L- Phe- L- Leu- L- Val- L-
Leu- L- Leu)
15. Marine originated
fungus
Biscogniauxia
mediterranea
isolated from a sediment collected
in the Eastern Mediterranean Sea
(2800 m depth)
Biscogniauxone Alkaloids
16. Marine originated
fungus
Penicillium sp.
KF620
isolated from the water sample of
the North Sea
Eutypoids B
Eutypoids C
Eutypoids D
Eutypoids E
17. marine- derived
fungus
Aspergillus sp.
strains LF666
isolated from a deep- sea sediment
sample which was collected from
the Mediterranean Sea
Pannorin oxygenated
18. marine- derived
fungus
Xylaria sp. obtained by
mangrove fungus of the South China
Sea coast.
Xyloketal B showed that the
TABLE 8.2 (Continued)
The structure of various chemical compounds isolated from marine sources of macroalgae

169
Marine Plant Species: Nutritional and Medicinal Value
cyclopentapeptide exhibited anti- AChE
activity with a
minimal inhibition
concentration
(MIC) = 5.87 µM.
Huperzine A
150
(isopyrrolonaph-
thoquinone)
IC
50
= 8.04 µM.
150
Phenolics (Aromatic
butenolides)
moderate inhibitory
activity against
IC
50
= 0.78, 0.67, 4.08,
and 2.26 µM,
respectively
151
oxygenated
benzo- coumarins
151
showed that the
modulation of
elements in the
could regulate neurons
state
152

170
Plant-based Foods and their Implications in Brain Health
TABLE 8.3
The structure of various chemical compounds isolated from marine sources of macroalgae
Macroalgae
Sl.
No. Marine source Scientific name
Source of
collection
Chemical compound
isolated Nature of chemical Chemical structure
1. brown alga Ecklonia maxima The aqueous
methanol extract
and organic
solvent fractions
of this algae,
collected on the
West coast of
South Africa
phloroglucinol Phenolics displayed anti-
dibenzo[1,4]
dioxine- 2,4,7,9- tetraol
eckol
2. red alga Grateloupia
elliptica
collected offshore of
Jeju Island, Korea
6,6´- bieckol Phenolics moderate inhibitory
3. red alga Symphyocladia
latiuscula
collected in Korean
water, by using a
Multiple Enzyme
Targets approach
2,3,6- tribromo- 4,5-
dihydroxybenzyl alcohol
Phenolics inhibited both

171
Marine Plant Species: Nutritional and Medicinal Value
Mechanism of
action
Results of animal
studies
Outcomes
of clinical
Studies References
displayed anti-
AChE inhibitory
activity with
IC
50
= 84.48
and 76.70 µM,
respectively
153
activity toward
AChE and
BuChE compared
to donepezil;
however, its anti-
BuChE activity
(IC
50
= 27.4 µM)
was more potent
than its anti-
AChE activity
(IC
50
= 44.5 µM)
154
inhibited both
AChE and
BuChE
activities, (IC
50
= 7.31 for AChE
and 8.95 µM for
BuChE)
155
(continued)

172
Plant-based Foods and their Implications in Brain Health
Macroalgae
Sl.
No. Marine source Scientific name
Source of
collection
Chemical compound
isolated Nature of chemical Chemical structure
2,3,6- tribromo- 4,5-
dihydroxybenzyl methyl
ether
bis- (2,3,6- tribromo- 4,5-
dihydroxybenzyl) ether
4. isolated from
different
populations of
a red alga
Laurencia
dendroidea
collected from the
coast of Brazil
(- ) elatol
halogenated
sesquiterpenes)
(+ )- elatol AChE inhibitory
(+ )- obtusol AChE inhibitory
(- )dendroidol AChE inhibitory
(- ) cartilagineol AChE inhibitory
TABLE 8.3 (Continued)
The structure of various chemical compounds isolated from marine sources of macroalgae

173
Marine Plant Species: Nutritional and Medicinal Value
Mechanism of
action
Results of animal
studies
Outcomes
of clinical
Studies References
inhibited both
AChE and
BuChE
activities, (IC
50
=
9.61 µM for AChE
and 14.41 µM
for BuChE)
inhibited both
AChE and
BuChE activities,
(IC
50
= 2.66 µM
for AChE and
4.03 µM for
BuChE),
AChE inhibitory
activity
156
activity
activity
activity
activity
(continued)
Соседние файлы в папке Библиотека им академика М.И. Перельмана
